Ann Marie O'Neill/aum.edu
May 20, 2026, 08:03
Ann Marie O’Neill: Help Us Improve Information for DOAC Medicines
Ann Marie O’Neill, Operations Manager at The Meath Foundation , Thrombosis Patient Advocate, shared a post on LinkedIn:
“We are inviting people who take Direct Oral Anticoagulant Medication (DOAC) eg. Apixaban (Eliquis) Rivaroxaban (Xaralto) or Dabigatran (Pradaxa) after experiencing a blood clot, to join a small focus group to help us improve our Patient information booklet.
If you are a VTE Health Care Professional, please share with your relevant Patients.
The more the merrier.”
Stay updated with Hemostasis Today.
-
Oct 15, 2026, 07:39Sian James: Welsh Blood Service Research Showcases Innovation and International Collaboration in Transfusion Medicine
-
Oct 15, 2026, 07:16Ruhi Mehra: Advancing Modern Transfusion Medicine Through Collaboration and Continuing Medical Education
-
Oct 15, 2026, 07:08Muhammet Özbilen: Iron Deficiency Beyond Hemoglobin Exploring Mitochondrial and Metabolic Dysfunction
-
Oct 15, 2026, 06:44Ahlem Slama: World Thrombosis Day 2026 Lighting Up Heritage to Raise Awareness
-
Oct 15, 2026, 06:32Joshua Muia: World Thrombosis Day 2026 Highlights Research on Tissue Factor and Blood Coagulation
-
Oct 14, 2026, 20:36How Does Inflammation Reshape Red Blood Cell Production? – ASH
-
Oct 14, 2026, 20:30Marilena Vrana: Putting Faces to the Chain – Donors and Patients Connect in Milan for IPAW 2026
-
Oct 14, 2026, 20:25Asim Alam: Hillsborough County and Partners Demonstrate Drone-Based Emergency Blood Delivery
-
Oct 14, 2026, 20:19Zahid Khanzada: 3rd Position in the Hematology Quiz at PCUH